EVO News and Press, Evotec SE From 04/17/25

2025-04-17 03:40:47 ET More on Evotec SE Seeking Alpha’s Quant Rating on Evotec SE Historical earnings data for Evotec SE Financial information for Evotec SE Read the full article on Seeking Alpha For further details see: Evotec SE reports ...

Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth Strategy builds on technology and science leadership, focusing on high-growth, high-value segments, simplifying the business model and fostering operational excellence Stron...

2025-04-16 18:44:01 ET Evotec SE (EVO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in EVO stock price following earnings has averaged ±5.11% , with a median of 2.08%. The single b...

2025-04-10 18:53:14 ET Below are the top 5 penny stocks screened from our system based on their highest market capitalization, traded volume and 1-Day Change% in Healthcare sector. CSPC Pharmaceutical Group Limited (CHJTF) CHJTF is trading UP for the last 1 days, and it at trading...

HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April 2025. The Company is going to host a conference call to discuss 2024 results as well as t...

2025-03-14 16:13:09 ET Summary Halozyme Therapeutics, Inc. has shown robust growth, with Q4 2024 earnings surpassing expectations and significant revenue increases driven by royalties from partnered products. The company's ENHANZE drug delivery platform enhances existing drugs, ge...

Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN:DE0005664809; NASDAQ:E...

2025-02-18 10:30:00 ET Summary Global stock markets ended 2024 on a down note, with US stocks outperforming due to AI enthusiasm and growth-oriented index heavyweights. The Global Small Companies Equity composite underperformed, mainly due to weak stocks in Industrials and IT sect...

2025-02-18 09:15:00 ET Summary US stocks outperformed international markets in Q4 2024, driven by growth-oriented large-cap stocks and optimism around Trump's business-friendly policies. International small caps fell 7.6% in Q4, largely due to currency weakness, despite a 3.9% gai...

Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and Energy Funding supports a novel collaboration to develop first-in-class therapeutic antibodies to treat asthma and idiopathic pulmon...